MUTHOOT FINANCE Q1FY22 BUSINESS UPDATES KEY BUSINESS UPDATES - CONSOLIDATED PERFORMANCE - KEY POINTS - * Break up of Muthoot Finance Assets in Muthoot group - 90% * Break up of Subsidiaries in Muthoot group - 10% ----------------------------------- KEY POINTS - * Break up of Muthoot Finance Assets in Muthoot group - 99% * Break up of Subsidiaries in Muthoot group - 1% -------------------------------- KEY POINTS - * Interest Income grow by 15% (y-o-y) * Total Income grow by 14% (y-o-y) * PBT is grown by 14% (y-o-y) * PAT is grown by 14% (y-o-y) ------------------------------ KEY POINTS - * Total loan book grow by 26.7% * Total Assets grow by 17.3% * Borrowing is grown by 13.2% * Borrowing from debt securities is grown by 47% ------------------------- MUTHOOT FINANCE STANDALONE PERFORMANCE - KEY POINTS - * Total Income is grown by 14% * Total Expenses is grown by 12% * PBT is grown by 16% * PAT is grown by 16% ---------------------------- KEY POINTS - * Total Go
Alkem Labs Q1FY22 Earning Call Highlights ANALYST - MR. TUSHAR MANUDHANE – MOTILAL OSWAL FINANCIAL SECURITIES LIMITED MANAGEMENT - MR. SANDEEP SINGH –MANAGING DIRECTOR - ALKEM LABORATORIES MR. RAJESH DUBEY – CHIEF FINANCIAL OFFICER - ALKEM LABORATORIES MR. AMIT GHARE – PRESIDENT (INTERNATIONAL BUSINESS) - ALKEM LABORATORIES MR. YOGESH KAUSHAL - PRESIDENT CHRONIC DIVISION - ALKEM LABORATORIES MR. GAGAN BORANA –INVESTOR RELATIONS - ALKEM LABORATORIES Key Q1FY22 Business Updates - * Revenue is growing by 37.1% (y-o-y) * EBITDA margins are at 21.7% (y-o-y) * PAT is growing by 11% (y-o-y) * Indian business is growing by 65.3% (y-o-y) * US business is degrowth by 9.3% (y-o-y) * Other Internation business is growing by 56.4% (y-o-y) * During the quarter, we filled 2 ANDA with US FDA and received 5 approvals Some Important Question-Answer - Q1 - Just on the sales growth outlook especially for India business given that it is a very high growth how do you see the rest of the year pannin